BRIEF published on 04/13/2026 at 07:05, 5 months 15 days ago ADS-TEC Energy dévoile ses résultats financiers préliminaires pour 2025 Résultats Financiers Baisse Des Revenus Transition D'entreprise Croissance Des Services Modèle Diversifié
BRIEF published on 04/13/2026 at 07:05, 5 months 15 days ago Transactions sur actions propres d'OENEO : bilan du 30 mars au 3 avril 2026 Marché Financier Rachat D'actions Transactions Stratégie Financière Oeneo
BRIEF published on 04/13/2026 at 07:05, 5 months 15 days ago Transactions in OENEO's own shares: summary from March 30 to April 3, 2026 Transactions Share Buyback Financial Market Financial Strategy Oeneo
BRIEF published on 04/13/2026 at 07:05, 5 months 15 days ago Innate Pharma : Mise à Jour du Capital et des Droits de Vote Droits De Vote Biotechnologie Actions Immunothérapie Innate Pharma
BRIEF published on 04/13/2026 at 07:05, 5 months 15 days ago Innate Pharma Updates Share and Voting Rights as of April 2026 Biotechnology Shares And Voting Rights Innate Pharma April 2026 Euronext Nasdaq
BRIEF published on 04/13/2026 at 07:05, 5 months 15 days ago Innate Pharma met à jour ses actions et ses droits de vote à compter d'avril 2026 Biotechnologie Innate Pharma Actions Et Droits De Vote Avril 2026 Euronext Nasdaq
BRIEF published on 04/13/2026 at 07:05, 5 months 15 days ago Innate Pharma: Capital and Voting Rights Update Voting Rights Biotechnology Actions Immunotherapy Innate Pharma
BRIEF published on 04/13/2026 at 07:05, 5 months 15 days ago Dupixent de Sanofi et Regeneron approuvé pour les jeunes enfants dans l'UE Dupixent Enfants Urticaire Chronique Sanofi Regeneron Approvisionnement UE
BRIEF published on 04/13/2026 at 07:05, 5 months 15 days ago Dupixent from Sanofi and Regeneron approved for young children in the EU Children Dupixent Chronic Urticaria Sanofi Regeneron EU Supply
BRIEF published on 04/13/2026 at 07:05, 5 months 15 days ago Sanofi and Regeneron’s Dupixent Gains EU Approval for Treating Young Children with CSU Sanofi Dupixent EU Approval Regeneron Chronic Spontaneous Urticaria
Published on 09/28/2026 at 15:00, 3 hours 47 minutes ago Vox to Acquire Silver Royalty over the Sorby Hills Project in Australia
Published on 09/28/2026 at 14:45, 4 hours 2 minutes ago Clinical Trial of the Oral Drug NV-387 to Treat Ebola Has Started Enrollment and Dosing of Patients Last Week (on or about September 23rd), Says NanoViricides
Published on 09/28/2026 at 14:30, 4 hours 17 minutes ago Drilling at Cat Creek Intersects a Copper-Molybdenum Porphyry System Visible Molybdenite-Chalcopyrite Over Significant Core Widths
Published on 09/28/2026 at 14:30, 4 hours 17 minutes ago Predictiv AI Completes United Nations Fleet Management Deployment Following Competitive Procurement Win
Published on 09/28/2026 at 14:00, 4 hours 47 minutes ago DoJ and DoW move to Support Resumption of Operations at Colosseum
Published on 09/28/2026 at 18:00, 47 minutes ago GEVELOT S.A.: Weekly declaration of share buybacks – 09/28/2026 (French only)
Published on 09/28/2026 at 18:00, 47 minutes ago GEVELOT S.A.: Déclaration hebdomadaire de rachat d'actions 28/09/2026
Published on 09/28/2026 at 17:53, 54 minutes ago EQS-Adhoc: MeVis Medical Solutions AG: Forecast Adjustment for Fiscal Year 2025/2026
Published on 09/28/2026 at 17:49, 57 minutes ago XTPL increased its global project pipeline in H1 2026, building more sales opportunities for subsequent periods
Published on 09/28/2026 at 17:45, 1 hour 2 minutes ago EQS-Adhoc: Airbus SE: Airbus reports share buyback transactions 21-25 September 2026
Published on 09/28/2026 at 17:54, 52 minutes ago Reporting on share buyback transactions carried out between September 21 and September 25, 2026
Published on 09/28/2026 at 17:54, 52 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 21 et le 25 septembre 2026
Published on 09/28/2026 at 17:35, 1 hour 12 minutes ago Déclaration hebdomadaire d'opérations effectuées du 21 au 25 septembre 2026
